Shaun Wynyard, New Zealand

Chief Operating Officer
Diatranz Otsuka Limited

Mr. Wynyard has been working in the field of xenotransplantation since 2006 starting in the Molecular Diagnostic Laboratory of Diatranz Otsuka Limited (DOL) where he helped develop a xenosafety program in support of early phase clinical trials and the establishment of a testing facility accredited to medical laboratory ISO standard 15189:2012. He has a background in molecular diagnostics with a special interest in assay development and validation. Mr. Wynyard has been managing and leading the business operations of DOL in New Zealand since November 2015 as General Manager before becoming a Director and COO in 2018.  Through these roles Mr. Wynyard has gained in-depth knowledge and direct experience of the practical realitites and commercial challenges faced by researchers and companies developing xenotransplant products.

Lectures by Shaun Wynyard

When Session Talk Title Room
12:30 - 13:30
Lunch & Learn — Otsuka Symposium Safety of clinical islet xenotransplantation Audimax Auditorium (A.030)

© 2020 IXA 2019